HIV Vaccine Research and Design (HIVRAD) Program (P01)

The summary for the HIV Vaccine Research and Design (HIVRAD) Program (P01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

HIV Vaccine Research and Design (HIVRAD) Program (P01): The HIV Vaccine Research and Design (HIVRAD) program is designed to fund projects that further address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. Applications for five years of support should include plans that have advanced past the exploratory stage and include preliminary data. Less fully developed applications can request less than 5 years of support to establish feasibility. Applications aimed at developing or optimizing a specific vaccine platform should lay out a research pathway with clear decision points. Extensive modeling of vaccine concepts in non-human primates may be included.

Federal Grant Title:	HIV Vaccine Research and Design (HIVRAD) Program (P01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-15-164
Type of Funding:	Grant
CFDA Numbers:	93.855, 93.856
CFDA Descriptions:	Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research
Current Application Deadline:	Jul 14, 2017
Original Application Deadline:	Jul 14, 2017
Posted Date:	Mar 31, 2015
Creation Date:	Mar 31, 2015
Archive Date:	Aug 14, 2017
Total Program Funding:	$5,000,000
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Independent school districts
Private institutions of higher education
Special district governments
Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
County governments
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-15-164.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed); • Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed); • Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (...; • Combating Antibiotic-Resistant Bacteria Interdisciplinary Units (CARBIRUs) (P01 Clinical T...; • Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CE...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translati...; • Integrative Research to Understand the Impact of Sex Differences on the Molecular Determin...; • Limited Competition: Mentored Research Career Development Program Award in Clinical and Tr...; • Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Option...; • Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clini...